Common Equity (Annual)

Common Equity: The sum of all common equity items.

Rockwell Medical, Inc. (RMTI) had Common Equity of $21.29M for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$83.61M
Net Income	$-8.59M
Cost of Goods Sold	$74.91M
Gross Profit	$8.70M
Operating Expenses	$90.28M
Operating Income	$-6.67M
Non-Operating Income/Expense	$-1.77M
Pre-Tax Income	$-8.44M
Normalized Pre-Tax Income	$-8.76M
Income after Taxes	$-8.44M
Income from Continuous Operations	$-8.44M
Consolidated Net Income/Loss	$-8.44M
Normalized Income after Taxes	$-8.76M
EBIT	$-6.67M
EBITDA	$-2.11M
Weighted-Average Shares Outstanding (Basic)	23.32M
Weighted-Average Shares Outstanding (Diluted)	23.32M
Earnings per Share (EPS) (Basic)	$-0.37
Earnings per Share (EPS) (Diluted)	$-0.37
Balance Sheet Financials
Current Assets	$28.77M
Property, Plant, and Equipment	$6.40M
Long-Term Assets	$23.40M
Total Assets	$52.17M
Current Liabilities	$16.64M
Long-Term Debt	$9.84M
Long-Term Liabilities	$14.24M
Total Liabilities	$30.88M
Common Equity	$21.29M
Tangible Shareholders Equity	$9.61M
Shareholders Equity	$21.29M
Common Shares Outstanding	29.13M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-9.41M
Cash Flow from Investing Activities	$-3.04M
Cash Flow from Financial Activities	$11.34M
Beginning Cash	$10.10M
End Cash	$8.98M
Increase/Decrease in Cash	$-1.12M
Stock-Based Compensation	$0.93M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.73
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.32
Debt to Equity Ratio	0.49
Gross Margin	10.41%
Operating Margin	-7.98%
EBIT Margin	-7.98%
EBITDA Margin	-2.52%
Pre-Tax Profit Margin	-10.09%
Profit Margin	-10.27%
Free Cash Flow	$-9.70M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.60
Inventory Turnover	12.76
Receiveable Turnover	7.67
Days Sales in Receivables	47.59
Return on Equity	-39.64%
Return on Tangible Equity	-87.81%
Return on Assets	-16.18%
Return on Investments	-27.11%
Book Value Per Share	$0.73
Free Cash Flow per Share	$-0.42
Operating Cash Flow per Share	$-0.40

Data from Zacks Investment Research, Inc.